Key result
DNMT inhibition attenuates disturbed flow-induced endothelial inflammation and atherosclerosis lesion formation.
In atherosclerosis, plaques preferentially develop in arterial regions of disturbed blood flow (d-flow), which alters endothelial gene expression and function. Here, we determined that d-flow regulates genome-wide DNA methylation patterns in a DNA methyltransferase-dependent (DNMT-dependent) manner. Induction of d-flow by partial carotid ligation surgery in a murine model induced DNMT1 in arterial endothelium. In cultured endothelial cells, DNMT1 was enhanced by oscillatory shear stress (OS), and reduction of DNMT with either the inhibitor 5-aza-2'-deoxycytidine (5Aza) or siRNA markedly reduced OS-induced endothelial inflammation. Moreover, administration of 5Aza reduced lesion formation in 2 mouse models of atherosclerosis. Using both reduced representation bisulfite sequencing (RRBS) and microarray, we determined that d-flow in the carotid artery resulted in hypermethylation within the promoters of 11 mechanosensitive genes and that 5Aza treatment restored normal methylation patterns. Of the identified genes, HoxA5 and Klf3 encode transcription factors that contain cAMP response elements, suggesting that the methylation status of these loci could serve as a mechanosensitive master switch in gene expression. Together, our results demonstrate that d-flow controls epigenomic DNA methylation patterns in a DNMT-dependent manner, which in turn alters endothelial gene expression and induces atherosclerosis.
No takes yet. Share an insight, caveat, or question.
Dunn et al. (2014) studied Atherosclerosis. 5-aza-2'-deoxycytidine (5Aza) was evaluated on Lesion formation and endothelial inflammation. Disturbed blood flow regulated epigenomic DNA methylation patterns via DNMT1 to induce atherosclerosis, while the DNMT inhibitor 5Aza attenuated endothelial inflammation and lesion formation.
Synapse has enriched 3 closely related papers on similar clinical questions. Consider them for comparative context: